Adimmune Corp
TWSE:4142
Adimmune Corp
Selling, General & Administrative
Adimmune Corp
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adimmune Corp
TWSE:4142
|
Selling, General & Administrative
-NT$787.9m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-14%
|
|
GenMont Biotech Inc
TWSE:3164
|
Selling, General & Administrative
-NT$154.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
1%
|
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
Selling, General & Administrative
-NT$63.1m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
See Also
What is Adimmune Corp's Selling, General & Administrative?
Selling, General & Administrative
-787.9m
TWD
Based on the financial report for Mar 31, 2024, Adimmune Corp's Selling, General & Administrative amounts to -787.9m TWD.
What is Adimmune Corp's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-14%
Over the last year, the Selling, General & Administrative growth was -54%. The average annual Selling, General & Administrative growth rates for Adimmune Corp have been -32% over the past three years , -28% over the past five years , and -14% over the past ten years .